Among injectable options, liraglutide is less expensive than other GLP-1 medications, as a generic version is available
For example, a 2011 study in rats found that the peptide successfully healed various lesions and promoted healthy weight gain in models of short-bowel syndrome.14 Additionally, as researchers note in the aforementioned 2016 review on BPC-157 and the gut-brain axis, BPC 157 was successful in the therapy of GI tract, periodontitis, liver and pancreas lesions, and in the healing of various tissues and wounds. Its also written in the review that the peptide acts as a mediator of Roberts cytoprotection, defined as the counteraction of the lesions arising from direct detrimental contact with a noxious agent.7 15 Insider Tip: Though there has been some small-scale positive human research on BPC-157, most of the peptides potential uses are based on the outcomes of animal or cell studies
I suspect it will hit the market from Eli Lilly in the next two to three years
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Earlier this month, Indias drug regulator warned companies against direct or surrogate advertising of weight loss drugs, including obesity awareness campaigns that could function as hidden promotion